The Company is developing a range of nutritional products to regulate energy absorption and utilisation generally and within this portfolio blood glucose management (hypo- and hyperglycaemia control). Applications include glycogen storage diseases, type I and type II diabetes, liver disease, sport nutrition and applications for consumer health more generally. Other applications include disease states associated with carbohydrate digestion/transport/metabolism/utilisation such as disorders specific to fructose, galactose, lactose, maltose and sucrose. 

What's new?

Portfolio of products under development.

Human clinical trials continue on the medical nutrition/nutrition portfolio the Company is developing.  Trials on blood glucose control with new clinical nutrition products (crackers) are successful for healthy people and people with glycogen storage diseases and type I/type II diabetes. Trials on blood glucose control with new nutrition products (energy bars) are successful for healthy people.